1. Home
  2. RKLB vs ROIV Comparison

RKLB vs ROIV Comparison

Compare RKLB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RKLB
  • ROIV
  • Stock Information
  • Founded
  • RKLB 2006
  • ROIV 2014
  • Country
  • RKLB United States
  • ROIV United Kingdom
  • Employees
  • RKLB N/A
  • ROIV N/A
  • Industry
  • RKLB Aerospace
  • ROIV Biotechnology: Pharmaceutical Preparations
  • Sector
  • RKLB Industrials
  • ROIV Health Care
  • Exchange
  • RKLB Nasdaq
  • ROIV Nasdaq
  • Market Cap
  • RKLB 7.4B
  • ROIV 8.4B
  • IPO Year
  • RKLB N/A
  • ROIV N/A
  • Fundamental
  • Price
  • RKLB $22.41
  • ROIV $11.83
  • Analyst Decision
  • RKLB Buy
  • ROIV Strong Buy
  • Analyst Count
  • RKLB 11
  • ROIV 9
  • Target Price
  • RKLB $16.50
  • ROIV $17.69
  • AVG Volume (30 Days)
  • RKLB 24.4M
  • ROIV 4.5M
  • Earning Date
  • RKLB 11-12-2024
  • ROIV 11-12-2024
  • Dividend Yield
  • RKLB N/A
  • ROIV N/A
  • EPS Growth
  • RKLB N/A
  • ROIV N/A
  • EPS
  • RKLB N/A
  • ROIV 5.89
  • Revenue
  • RKLB $363,817,000.00
  • ROIV $129,128,999.00
  • Revenue This Year
  • RKLB $76.53
  • ROIV $48.37
  • Revenue Next Year
  • RKLB $40.92
  • ROIV $13.76
  • P/E Ratio
  • RKLB N/A
  • ROIV $2.01
  • Revenue Growth
  • RKLB 53.92
  • ROIV 145.68
  • 52 Week Low
  • RKLB $3.47
  • ROIV $8.61
  • 52 Week High
  • RKLB $22.55
  • ROIV $13.06
  • Technical
  • Relative Strength Index (RSI)
  • RKLB 83.52
  • ROIV 51.97
  • Support Level
  • RKLB $16.80
  • ROIV $11.05
  • Resistance Level
  • RKLB $20.97
  • ROIV $12.05
  • Average True Range (ATR)
  • RKLB 1.61
  • ROIV 0.30
  • MACD
  • RKLB 0.72
  • ROIV -0.02
  • Stochastic Oscillator
  • RKLB 98.79
  • ROIV 61.86

About RKLB Rocket Lab USA Inc.

Rocket Lab USA Inc is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments being Launch Services and Space systems. Geographically it serves Japan, Germany, rest of the world and earns key revenue from the United States.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: